Showing results (321-330 of 442) with videos related to
Sort By:
Pageof 45
Cancer Investigation|September 14, 2007
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding studyM Reni, S Cereda, E Bonetto, et al.Diabetes Care|November 1, 1986
Free-insulin profiles after intraperitoneal, intramuscular, and subcutaneous insulin administrationP Micossi, M Cristallo, M C Librenti, et al.The Journal of Surgical Research|March 1, 1996
Effect of endotoxemia on intestinal villus microcirculation in ratsH Schmidt, A Secchi, R Wellmann, et al.American Journal of Clinical Oncology|April 9, 2008
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapyM Reni, S Cereda, E Mazza, et al.La Radiologia Medica|October 1, 1990
[Description and results of a simplified procedure for intraoperative electron radiotherapy]V Fossati, G M Cattaneo, M Carlucci, et al.Cancer Investigation|December 8, 2004
Salvage chemotherapy with mitomycin, docetaxel, and irinotecan (MDI regimen) in metastatic pancreatic adenocarcinoma: a phase I and II trialMichele Reni, M G Panucci, P Passoni, et al.Surgery|February 1, 1994
Role of B72.3 iodine 125-labeled monoclonal antibody in colorectal cancer detection by radioimmunoguided surgeryV Di Carlo, F Badellino, M Stella, et al.Cancer Chemotherapy and Pharmacology|June 30, 2006
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinomaM Reni, S Cereda, E Bonetto, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 12, 2008
Protein and glutamine kinetics during counter-regulatory failure in type 1 diabetesA Battezzati, S Benedini, L P Sereni, et al.Microvascular Research|July 31, 1998
Measurement of blood flow in the main arteriole of the villi in rat small intestine with FITC-labeled erythrocytesJ Ruh, E Ryschich, A Secchi, et al.Pageof 45